Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-19T19:31:30.759Z Has data issue: false hasContentIssue false
  • English
  • Français

Prolonged Hospital Stay, an Adverse Effect of Strict National Policy for Controlling the Spread of Highly Resistant Microorganisms

Published online by Cambridge University Press:  10 May 2016

Gabriel Birgand ,
Michael Schwarzinger ,
Anne Perozziello ,
Isabelle Lolom ,
Camille Pelat ,
Laurence Armand-Lefevre ,
Jean-Claude Buzzi ,
Antoine Andremont ,
Yazdan Yazdanpanah  and
Jean-Christophe Lucet
Gabriel Birgand*
Affiliation:
INSERM, IAME, Unité Mixte de Recherche (UMR) 1137, Paris, France Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France AP-HP, Hôpital Bichat, Infection Control Unit, Paris, France
Michael Schwarzinger
Affiliation:
INSERM, IAME, Unité Mixte de Recherche (UMR) 1137, Paris, France Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France
Anne Perozziello
Affiliation:
Medical Information Systems Program (PMSI), Bichat-Claude Bernard Hospital, Paris, France
Isabelle Lolom
Affiliation:
AP-HP, Hôpital Bichat, Infection Control Unit, Paris, France
Camille Pelat
Affiliation:
INSERM, IAME, Unité Mixte de Recherche (UMR) 1137, Paris, France Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France
Laurence Armand-Lefevre
Affiliation:
Bacteriology Laboratory, Bichat-Claude Bernard Hospital, Paris, France
Jean-Claude Buzzi
Affiliation:
Medical Information Systems Program (PMSI), Bichat-Claude Bernard Hospital, Paris, France
Antoine Andremont
Affiliation:
Bacteriology Laboratory, Bichat-Claude Bernard Hospital, Paris, France
Yazdan Yazdanpanah
Affiliation:
INSERM, IAME, Unité Mixte de Recherche (UMR) 1137, Paris, France Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France AP-HP, Service de Maladies Infectieuses et Tropicales, Bichat-Claude Bernard Hospital, Paris, France
Jean-Christophe Lucet
Affiliation:
INSERM, IAME, Unité Mixte de Recherche (UMR) 1137, Paris, France Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France AP-HP, Hôpital Bichat, Infection Control Unit, Paris, France
*
Unité d’Hygiène et de Lutte contre l’Infection Nosocomiale, GH Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France (gbirgand@gmail.com)
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 11 , November 2014 , pp. 1427 - 1429
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Cantón, R, Akóva, M, Carmeli, Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012;18:413–431.CrossRefGoogle ScholarPubMed
2. European Centre for Disease Prevention and Control (ECDC). Carbapenemase-producing bacteria in Europe: interim results from the European survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project 2013. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf. Accessed June 13, 2014.Google Scholar
3. ECDC. Antimicrobial resistance surveillance in Europe. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf. Accessed June 13, 2014.Google Scholar
4. Haut Conseil de la Santé Publique. Prévention de la transmission croisée des Bactéries Hautement Résistantes aux antibiotiques émergentes (BHRe). http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372. Accessed June 13, 2014.Google Scholar
5. Agence Technique de l’Information sur l’Hospitalisation. Echelle nationale de coûts par GHM (en euros), référentiel national de coûts. 2011. http://wwwatihsantefr/. Accessed June 13, 2014.Google Scholar
6. Horan, TC, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.CrossRefGoogle ScholarPubMed
7. European Center for Disease Prevention And Control. Antimicrobial resistance interactive database (EARS-Net). http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx. Accessed June 13, 2014.Google Scholar
8. Fournier, S, Brun-Buisson, C, Jarlier, V. Twenty years of antimicrobial resistance control programme in a regional multi-hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control 2012;1:9.CrossRefGoogle Scholar
9. Morgan, DJ, Diekema, DJ, Sepkowitz, K, Perencevich, EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 37, 85–93 (2009).CrossRefGoogle ScholarPubMed
10. Birgand, G, Ruimy, R, Schwarzinger, M, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control 2013;2:30.CrossRefGoogle ScholarPubMed